Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease
- Authors: Tikhomirova AS1, Kislyakov VA1, Baykova IE1, Nikitin IG1,2
-
Affiliations:
- N.I. Pirogov Russian national research medical University, Ministry of health of Russia
- Higher Medical rehabilitation center, Ministry of health of Russia
- Issue: Vol 90, No 2 (2018)
- Pages: 85-88
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/32840
- DOI: https://doi.org/10.26442/terarkh201890285-88
- ID: 32840
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A S Tikhomirova
N.I. Pirogov Russian national research medical University, Ministry of health of Russia
Email: dr.tikhomirovaas@gmail.com
аспирант каф. госпитальной терапии №2 лечебного факультета РНИМУ им. Н.И. Пирогова Москва, Россия
V A Kislyakov
N.I. Pirogov Russian national research medical University, Ministry of health of Russiaк.м.н., доц. каф. госпитальной терапии №2 лечебного факультета РНИМУ им. Н.И. Пирогова Москва, Россия
I E Baykova
N.I. Pirogov Russian national research medical University, Ministry of health of Russiaк.м.н., доц. каф. госпитальной терапии №2 лечебного факультета РНИМУ им. Н.И. Пирогова Москва, Россия
I G Nikitin
N.I. Pirogov Russian national research medical University, Ministry of health of Russia; Higher Medical rehabilitation center, Ministry of health of Russiaд.м.н., проф., зав. каф. госпитальной терапии №2 лечебного факультета РНИМУ им. Н.И. Пирогова; директор ФГАУ «Лечебно-реабилитационный центр» Минздрава России Москва, Россия
References
- De Alwis N.M.W, Day C.P. Non - alcoholic fatty liver disease: Them its gradually clears. J Hepatol. 2008;48:104-12.
- Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53:372-84.
- Vernon G, Baranova A, Younossi Z.M. Systematic review: the epidemiology and natural history of non - alcoholic fatty liver disease and non - alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274-85.
- Miele L, Beale G, Patman G, et al. The Kruppel - like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease. Gastroenterology. 2008;35(1):282-91.
- Romeo S, Kozlitina J, Xing C, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461-5.
- Day C.P, James O.F. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114:842-5.
- Pingitore P, Pirazzi C, Mancina R.M, et al. Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function. Biochim Biophys Acta. 2014;1841:574-80.
- Pirazzi C, Valenti L, Motta B.M, et al. PNPLA3 has retinyl - palmitate lipase activity in human hepatic stellate cells. Hum Mol Genet. 2014;23(15):4077-85.
- Sookoian S, Castaño G.O, Burgueño A.L, et al. A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity. J Lipid Res. 2009;50(10):2111-6.
- Valenti L, Al-Serri A, Daly A.K, et al. Homozygosity for the patatin - like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51(4):1209-17.
- Speliotes E.K, Butler J.L, Palmer C.D, et al. PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease. Hepatology (Baltimore). 2010;52(3):904-12.
- Rotman Y, Koh C, Zmuda J.M, Kleiner D.E, Liang T.J. The Association of Genetic Variability in PNPLA3 with Histological Severity of Non-Alcoholic Fatty Liver Disease. Hepatology (Baltimore). 2010;52(3):894-903.
- Sookoian S, Pirola C.J. Meta - analysis of the influence of I148M variant of patatin - like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology. 2011;53(6):1883-94.
- Shen J.H, Li Y.L, Li D, Wang N.N, Jing L, Huang Y.H. The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta - analysis. J Lipid Res. 2015;56(1):167-75.
- Cox A.J, Wing M.R, Carr J.J, et al. Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus. Diabet Metab. 2011;37(5):452-5.
- Kantartzis K, Peter A, Machicao F, et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin - like phospholipase 3 gene. Diabetes. 2009;58(11):2616-23.
- Palmer C.N.A, Maglio C, Pirazzi C, et al. Paradoxical Lower Serum Triglyceride Levels and Higher Type 2 Diabetes Mellitus Susceptibility in Obese Individuals with the PNPLA3 148M Variant. Hennige AM, ed. PLoS ONE. 2012;7(6):e39362.
- Stojkovic I.A, Ericson U, Rukh G, Riddestråle M, Romeo S, Orho-Melander M. The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels. Genes Nutr. 2014;9:200-9.
- Tang C.S, Zhang H, Cheung C.Y, et al. Exome - wide association analysis reveals novel coding sequence variants associated with lipid traits in Chinese. Nat Commun. 2015;6:10206.
- Speliotes E.K, Yerges-Armstrong L.M, Wu J, Hernaez R, Kim L.J, et al. Genome-Wide Association Analysis Identifies Variants Associated withNonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits. PLoS Genet. 2011;7(3):e1001324.
- Petit J.M, Guiu B, Masson D, et al. Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes. J Clin Endocrinol Metab. 2010;95:430-6.
- Krawczyk M, Grünhage F, Zimmer V, et al. Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non - invasive elastography - based study in chronic liver disease. J Hepatol. 2011;55: 299-306.
- Valenti L, Alisi A, Galmozzi E, et al. I148M patatin - like phospholipase domain - containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology. 2010;52(4):1274-80.
- Singal A.G, Manjunath H, Yopp A.C, et al. The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta - analysis. Review. Am J Gastroenterol. 2014;109(3):325-34.
- Khlaiphuengsin A, Kiatbumrung R, Payungporn S, et al. Association of PNPLA3 Polymorphism with Hepatocellular Carcinoma Development and Prognosis in Viral and Non-Viral Chronic Liver Diseases. Asian Pac J Cancer Prev. 2015;16(18):8377-82.
- Abecasis G.R, Auton A, Brooks L.D, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56-65.
- Browning J.D, Szczepaniak L.S, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-95.
- Browning J.D, Kumar K.S, Saboorian M.H, Thiele D.L. Ethnic differences in the prevalence of cryptogenic cirrhosis. Am J Gastroenterol. 2004;99:292-8.
- Palmer N.D, Musani S.K, Yerges-Armstrong L.M, et al. Characterization of European ancestry nonalcoholic fatty liver disease - associated variants in individuals of African and Hispanic descent. Hepatology. 2013;58:966-75.
- Qu H.Q, Li Q, Grove M.L, et al. Population - based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population. Arch Med Res. 2012;43:482-8.
- Peng X.E, Wu Y.L, Lin S.W, et al. Genetic variants in PNPLA3 and risk of non - alcoholic fatty liver disease in a Han Chinese population. PLoS One. 2012;7:e50256.
- Li Y, Xing C, Tian Z, Ku H.C. Genetic variant I148M in PNPLA3 is associated with the ultrasonography - determined steatosis degree in a Chinese population. BMC Med Genet. 2012;13:113.
- Kitamoto T, Kitamoto A, Yoneda M, et al. Genome - wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum Genet. 2013;132:783-92.
- Lee S.S, Byoun Y.S, Jeong S.H, et al. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea. Dig Dis Sci. 2014;59:2967-74.
- Bhatt S.P, Nigam P, Misra A, et al. Genetic variation in the patatin - like phospholipase domain - containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease. Metab Syndr Relat Disord. 2013;11:329-35.
- Kanth V.R, Sasikala M, Rao P.N, et al. Pooled genetic analysis in ultrasound measured non - alcoholic fatty liver disease in Indian subjects: A pilot study. World J Hepatol. 2014;6:435-42.
- Dubuquoy C, Robichon C, Lasnier F, et al. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. J Hepatol. 2011;55:145-53.
- He S, Mc Phaul C, Li J.Z, et al. A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis. J Biol Chem. 2010;285(9):6706-15.
- Smagris E, Basu Ray S, Li J, et al. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Hepatology (Baltimore). 2015;61(1):108-18.
- Pirazzi C, Adiels M, Burza M.A, et al. Patatin - like phospholipase domain - containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. J Hepatol. 2012;57:1276-82.
- Mondul A, Mancina R.M, Merlo A, et al. PNPLA3 I148M variant influences circulating retinol in adults with nonalcoholic fatty liver disease or obesity. J Nutr. 2015;145:1687-91.
- Kovarova M, Konigsrainer I, Konigsrainer A, et al. The genetic variant I148M in PNPLA3 is associated with increased hepatic retinyl - palmitate storage in humans. J Clin Endocrinol Metab. 2015;100:1568-74.
- Moreira R.K. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med. 2007 Nov;131(11):1728-34.